Julian Smith-Voudouris

Julian Smith-Voudouris

Auto-generated profile, based on publicly available information

Julian Smith-Voudouris

Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2021 in Cancer Research
Verified
Journal Article
Open access
PDF file
QGQianyu Guo
Qianyu Guo
MBMargarita Bartish
Margarita Bartish
CGChristophe Gonçalves
Christophe Gonçalves
FHFan Huang
Fan Huang
JSJulian Smith-Voudouris
Julian Smith-Voudouris
WMWilson H Miller
Wilson H Miller
Breast cancer diagnosed within 10 years following childbirth is defined as postpartum breast cancer (PPBC) and is highly metastatic. Interactions between immune cells and other stromal cells within the involuting mammary gland are fundamental in facilitating an aggressive tumor phenotype. The MNK1/2–eIF4E axis promotes translation of prometastatic mRNAs in tumor cells, but its role in modulating the function of nontumor cells in the PPBC microenvironment has not been explored. Here, we used a combination of in vivo PPBC models and in vitro assays to study the effects of inactivation of the MNK1/2–eIF4E axis on the protumor function of select cells of the tumor microenvironment. PPBC mice deficient for phospho-eIF4E (eIF4ES209A) were protected against lung metastasis and exhibited differences in the tumor and lung immune microenvironment compared with wild-type mice. Moreover, the expression of fibroblast-derived IL33, an alarmin known to induce invasion, was repressed upon MNK1/2–eIF4E axis inhibition. Imaging mass cytometry on PPBC and non-PPBC patient samples indicated that human PPBC contains phospho-eIF4E high–expressing tumor cells and CD8+ T cells displaying markers of an activated dysfunctional phenotype. Finally, inhibition of MNK1/2 combined with anti–PD-1 therapy blocked lung metastasis of PPBC. These findings implicate the involvement of the MNK1/2–eIF4E axis during PPBC metastasis and suggest a promising immunomodulatory route to enhance the efficacy of immunotherapy by blocking phospho-eIF4E. Significance: This study investigates the MNK1/2–eIF4E signaling axis in tumor and stromal cells in metastatic breast cancer and reveals that MNK1/2 inhibition suppresses metastasis and sensitizes tumors to anti–PD-1 immunotherapy.

16 August 2024 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Closed access
ASAndrew Salib
Andrew Salib
JSJoshua G. Sanchez
Joshua G. Sanchez
LHLenique Huggins
Lenique Huggins
ASAnthony E. Seddio
Anthony E. Seddio
MDMeera M. Dhodapkar
Meera M. Dhodapkar
JGJonathan N Grauer
Jonathan N Grauer

18 April 2024 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
JSJulian Smith-Voudouris
Julian Smith-Voudouris
LRLee E. Rubin
Lee E. Rubin
JGJonathan N Grauer
Jonathan N Grauer
Introduction: Total knee arthroplasty (TKA) is a common procedure for which patient factors are known to affect perioperative outcomes. Asthma has not been specifically considered in this regard, although it is the most common inflammatory airway disease and predisposes to osteoarthritis. Methods: Adult patients undergoing TKA were identified from 2015 to 2021-Q3 M157 PearlDiver data sets. Asthma patients were matched to those without 1:1 based on age, sex, and Elixhauser Comorbidity Index (ECI). The incidence of 90-day adverse events and 5-year revisions were compared using multivariable logistic regression (P < 0.0023). The matched asthma group was then stratified based on disease severity for analysis of 90-day aggregated (any, severe, and minor) adverse events. Results: Among 721,686 TKA patients, asthma was noted for 76,125 (10.5%). Multivariable analysis revealed that patients with asthma were at increased odds of multiple 90-day pulmonary, non-pulmonary, and aggregated adverse events, as well as emergency department visits. Furthermore, patients with asthma had 1.17 times greater odds of 5-year revisions (P < 0.0001). Upon secondary analysis stratifying asthma by severity, patients with all severity levels of asthma showed elevated odds of adverse events after TKA. These associations increased in odds with increasing severity of asthma. Discussion: Over one-tenth of patients undergoing TKA were identified as having asthma, and these patients were at greater odds of numerous pulmonary and non-pulmonary adverse events (a trend that increased with asthma severity), as well as 5-year revisions. Clearly, patients with asthma need specific risk mitigation strategies when considering TKA. Level of evidence: III

14 July 2022 in Matrix Biology
Verified
Journal Article
Open access
SPSamuel E.J. Preston
Samuel E.J. Preston
MBMargarita Bartish
Margarita Bartish
VRVincent R. Richard
Vincent R. Richard
AAArash Aghigh
Arash Aghigh
CGChristophe Gonçalves
Christophe Gonçalves
SRSonia V. Del Rincón
Sonia V. Del Rincón
The extracellular matrix (ECM) plays critical roles in breast cancer development. Whether ECM composition is regulated by the phosphorylation of eIF4E on serine 209, an event required for tumorigenesis, has not been explored. Herein, we used proteomics and mouse modeling to investigate the impact of mutating serine 209 to alanine on eIF4E (i.e., S209A) on mammary gland (MG) ECM. The proteomic data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD028953. We discovered that S209A knock-in mice, expressing a non-phosphorylatable form of eIF4E, have less collagen-I deposition in native and tumor-bearing MGs, leading to altered tumor cell invasion. Additionally, phospho-eIF4E deficiency impacts collagen topology; fibers at the tumor-stroma boundary in phospho-eIF4E-deficient mice run parallel to the tumor edge but radiate outwards in wild-type mice. Finally, a phospho-eIF4E-deficient tumor microenvironment resists anti-PD-1 therapy-induced collagen deposition, correlating with an increased anti-tumor response to immunotherapy. Clinically, we showed that collagen-I and phospho-eIF4E are positively correlated in human breast cancer samples, and that stromal phospho-eIF4E expression is influenced by tumor proximity. Together, our work defines the importance of phosphorylation of eIF4E on S209 as a regulator of MG collagen architecture in the tumor microenvironment, thereby positioning phospho-eIF4E as a therapeutic target to augment response to therapy.

17 November 2024 in North American Spine Society Journal (NASSJ)
Verified
Journal Article
Open access
ASAnthony E. Seddio
Anthony E. Seddio
BKBeatrice M. Katsnelson
Beatrice M. Katsnelson
JSJulian Smith-Voudouris
Julian Smith-Voudouris
MGMichael J. Gouzoulis
Michael J. Gouzoulis
WDWesley Day
Wesley Day
JGJonathan N Grauer
Jonathan N Grauer
Background: Posterior lumbar fusion (PLF) is a common spine surgery that may be considered in patients with underlying comorbidities, such as inflammatory bowel disease (IBD). Prior literature examining the association of this disease and PLF outcomes was done in the National Inpatient Sample (NIS), which only assessed in-hospital data and did not reveal an elevated risk of medical or surgical complications. However, characterization of PLF outcomes beyond hospital discharge is important and remains unknown for patients with IBD. Methods: Patients with IBD who underwent single-level PLF +/- interbody fusion were identified from the M165Ortho PearlDiver database. Exclusion criteria included: patients < 18 years old, those undergoing concurrent cervical, thoracic, anterior, or multi-level fusion, those with prior trauma, neoplasm, or infection diagnosed within 90-days, and < 90-days of follow-up. Adult patients with IBD were matched 1:4 with non-IBD patients based on age, sex, and Elixhauser Comorbidity Index (ECI). The odds of 90-day individual and aggregated any, severe, and minor adverse events (AAE, SAE, and MAE, respectively), emergency department (ED) visits, and hospital readmission were compared by multivariable logistic regression. Five-year reoperation was assessed by Kaplan-Meier survival analysis and compared by log-rank test. Results: Overall, 4,392 (1.4%) of patients undergoing PLF were identified with IBD. These patients demonstrated elevated odds ratios (ORs) of aggregated MAE (OR 2.29), AAE (OR 2.27), and SAE (OR 1.84), as well as ED visits (OR 2.69) ( p < .001 for all). Conversely, 5-year reoperation rates were not different for those with vs without IBD ( p = .70). Conclusions: The current study highlights the importance of investigating post-discharge outcomes, as these findings were not detected by prior inpatient literature. Our findings reveal the odds of various complications may be significantly elevated for IBD patients within 90-days postoperatively, however, these inferior outcomes encouragingly did not translate to an elevated rate of 5-year reoperation.

18 December 2025 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
JSJoshua G. Sanchez
Joshua G. Sanchez
JSJulian Smith-Voudouris
Julian Smith-Voudouris
KZKatie M. Zehner
Katie M. Zehner
SHScott J. Halperin
Scott J. Halperin
SJSahir S. Jabbouri
Sahir S. Jabbouri
JGJonathan N Grauer
Jonathan N Grauer